Literature DB >> 35143028

Identification of Common Pathogenic Pathways Involved in Hemochromatosis Arthritis and Calcium Pyrophosphate Deposition Disease: a Review.

Elizabeth Mitton-Fitzgerald1, Claudia M Gohr1, Charlene M Williams2, Ann K Rosenthal3,4.   

Abstract

OBJECTIVES: Arthritis is a common clinical manifestation of hereditary hemochromatosis (HH), and HH is one of a handful of conditions linked to calcium pyrophosphate deposition (CPPD) in joints. The connection between these two types of arthritis has not yet been fully elucidated. In light of new pathogenic pathways recently implicated in CPPD involving bone, we reviewed the literature on the etiology of hemochromatosis arthropathy (HHA) seeking shared pathogenic mechanisms.
RESULTS: Clinical observations reinforce striking similarities between HHA and CPPD even in the absence of CPP crystals. They share a similar joint distribution, low grade synovial inflammation, and generalized bone loss. Excess iron damages chondrocytes and bone cells in vitro. While direct effects of iron on cartilage are not consistently seen in animal models of HH, there is decreased osteoblast alkaline phosphatase activity, and increased osteoclastogenesis. These abnormalities are also seen in CPPD. Joint repair processes may also be impaired in both CPPD and HHA.
CONCLUSIONS: Possible shared pathogenic pathways relate more to bone and abnormal damage/repair mechanisms than direct damage to articular cartilage. While additional work is necessary to fully understand the pathogenesis of arthritis in HH and to firmly establish causal links with CPPD, this review provides some plausible hypotheses explaining the overlap of these two forms of arthritis.
© 2022. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.

Entities:  

Keywords:  Calcium pyrophosphate; Hemochromatosis; Hemochromatosis arthropathy; Iron overload; Pseudogout

Mesh:

Substances:

Year:  2022        PMID: 35143028     DOI: 10.1007/s11926-022-01054-w

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  37 in total

1.  HEMOCHROMATOSIS AND ARTHRITIS.

Authors:  H R SCHUMACHER
Journal:  Arthritis Rheum       Date:  1964-02

2.  Transforming growth factor beta 1 stimulates inorganic pyrophosphate elaboration by porcine cartilage.

Authors:  A K Rosenthal; H S Cheung; L M Ryan
Journal:  Arthritis Rheum       Date:  1991-07

Review 3.  Update on calcium pyrophosphate deposition.

Authors:  Abhishek Abhishek; Michael Doherty
Journal:  Clin Exp Rheumatol       Date:  2016-07-22       Impact factor: 4.473

4.  Bone mineral density in men with genetic hemochromatosis and HFE gene mutation.

Authors:  P Guggenbuhl; Y Deugnier; J F Boisdet; Y Rolland; A Perdriger; Y Pawlotsky; G Chalès
Journal:  Osteoporos Int       Date:  2005-06-01       Impact factor: 4.507

5.  Mutations in ANKH cause chondrocalcinosis.

Authors:  Adrian Pendleton; Michelle D Johnson; Anne Hughes; Kyle A Gurley; Andrew M Ho; Michael Doherty; Josh Dixey; Pierre Gillet; Damien Loeuille; Rodney McGrath; Antonio Reginato; Rita Shiang; Gary Wright; Patrick Netter; Charlene Williams; David M Kingsley
Journal:  Am J Hum Genet       Date:  2002-09-20       Impact factor: 11.025

6.  Intracellular and extracellular CPPD crystals are a regular feature in synovial fluid from uninflamed joints of patients with CPPD related arthropathy.

Authors:  A Martínez Sanchis; E Pascual
Journal:  Ann Rheum Dis       Date:  2005-06-07       Impact factor: 19.103

7.  Association between iron overload and osteoporosis in patients with hereditary hemochromatosis.

Authors:  L Valenti; M Varenna; A L Fracanzani; V Rossi; S Fargion; L Sinigaglia
Journal:  Osteoporos Int       Date:  2008-07-26       Impact factor: 4.507

8.  Phenotypic analysis of hemochromatosis subtypes reveals variations in severity of iron overload and clinical disease.

Authors:  Kam Sandhu; Kaledas Flintoff; Mark D Chatfield; Jeannette L Dixon; Louise E Ramm; Grant A Ramm; Lawrie W Powell; V Nathan Subramaniam; Daniel F Wallace
Journal:  Blood       Date:  2018-05-09       Impact factor: 22.113

9.  Inhibition of TGF-β signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis.

Authors:  Gehua Zhen; Chunyi Wen; Xiaofeng Jia; Yu Li; Janet L Crane; Simon C Mears; Frederic B Askin; Frank J Frassica; Weizhong Chang; Jie Yao; John A Carrino; Andrew Cosgarea; Dmitri Artemov; Qianming Chen; Zhihe Zhao; Xuedong Zhou; Lee Riley; Paul Sponseller; Mei Wan; William Weijia Lu; Xu Cao
Journal:  Nat Med       Date:  2013-05-19       Impact factor: 53.440

10.  Osteoclasts degrade bone and cartilage knee joint compartments through different resorption processes.

Authors:  Henrik Löfvall; Hannah Newbould; Morten A Karsdal; Morten H Dziegiel; Johan Richter; Kim Henriksen; Christian S Thudium
Journal:  Arthritis Res Ther       Date:  2018-04-10       Impact factor: 5.156

View more
  1 in total

1.  Histone Deacetylase Inhibitors Downregulate Calcium Pyrophosphate Crystal Formation in Human Articular Chondrocytes.

Authors:  Chi-Ching Chang; Kun-Lin Lee; Tze-Sian Chan; Chia-Chen Chung; Yu-Chih Liang
Journal:  Int J Mol Sci       Date:  2022-02-26       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.